Study: Stopping GLP-1 Drugs Increases Heart Attack and Stroke Risk
By
siquick
Master baker tier. Every paragraph earns its place on the tray.
Summary
New research published in BMJ Medicine reveals that stopping GLP-1 drugs (originally for diabetes, now popular for weight loss) leads to a rapid increase in heart attack and stroke risk, along with weight regain. The study highlights that while there's significant enthusiasm for starting these medications, there's insufficient attention to the consequences of discontinuation, which can cause a 'whiplash' effect where cardiovascular benefits quickly reverse.
Key quotes
· 3 pulledThere is enormous exuberance about starting GLP-1 drugs, but not nearly enough attention to what happens when people stop
What happens when you stop taking them, though? We know the weight tends to return, but research published today in BMJ Medicine shows some of the other benefits of GLP-1s vanish as well
The more GLP-1s catch on, the more benefits researchers discover. Originally formulated to treat diabetes, the popular weight-loss drugs have been shown to improve kidney health, liver function, cardiovascular disease, arthritis, and even dementia and addiction
You might also wanna read
Health officials urge weight loss jab users to call 111 if they experience serious side effects
The article warns Brits using weight loss jabs (GLP-1 inhibitors) about a potentially dangerous side effect affecting around 1 in 100 patien
mirror.co.uk·10h ago
GLP-1 Prescriptions Rise as U.S. Obesity Rates Show Modest Decline, New Data Indicates
New data from EPIC Research shows that GLP-1 medications like Ozempic and Wegovy are having a population-wide impact on obesity rates. As pr
gizmodo.com·2d ago
Satirical Examination of GLP-1 Weight-Loss Medication Myths and Facts
The article is a satirical piece from The Onion that humorously examines myths and facts about GLP-1 weight-loss medications. It presents ab
The Onion·1mo ago
GLP-1 weight loss drugs reduce food spending, creating a $6.5 billion challenge for major grocery retailers
The article discusses how GLP-1 weight loss drugs like tirzepatide are significantly impacting consumer spending on food, creating a $6.5 bi
bit.ly·4d ago